Dec 7, 2020 - 21 min
"Lots of people will try to get it early — even if no one admits to it." The US' Food and Drugs Administration (FDA) has given Pfizer & BioNTech's mRNA vaccine the green light and is expected to do the same with Moderna's very soon. However, quantities are still very limited and many are concerned about who will get early access to it. In the Financial Times, Gillian Tett analyses why the lack of a single-payer healthcare system in the US as well as the fragmentation of states, pose severe ethical questions to the vaccine's distribution plans in the country.